Skip to main content

Fiscal Wizard · Single-issue tearsheet

BIO-B / Jun 21, 2026 Run #7437

BIO-B

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Composite verdict

A 75.9 / 100
Bullish setup · Trend Following 12 drivers · 2 gates blocking
  • Ultimate Oscillator
  • Aroon Oscillator
  • ADX DI Cross
Consider long call target Δ ~0.70 · ~35 DTE Bullish setup, Grade A → ITM call target

Industry rank 5th of 141 in Medical Devices

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 14 signals0% Bear
Momentum Bullish 93Mean-reversion Neutral 57
  • Pullback buyOversold in an uptrend — a pullback buy: mean-reversion aligned with the primary trend, the high-value case for an oversold signal. (medium confidence)
Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Mixed

51.9 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Cash Conversion 0
EBITDA Margin 79
Inventory Turnover 0
Greenblatt ROC 79
Cash Conversion Cycle 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Ultimate Oscillator, Aroon Oscillator, ADX DI Cross); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Ultimate Oscillator 88
Aroon Oscillator 81
ADX DI Cross 81

Risk Gates

2 blocking 5 caution

2 guards active, 14 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Beneish M-Score Caution

Bottom-band Beneish M blocks bullish signals — accounting-quality risk.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for BIO-B.